Optiver Holding B.V. Kymera Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 322 shares of KYMR stock, worth $20,405. This represents 0.0% of its overall portfolio holdings.
Number of Shares
322Holding current value
$20,405% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
228Shares Held
73.2MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$435 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$422 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$415 Million5.22% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$349 Million9.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.42MShares$344 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.47B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...